The startup develops HiDef-B8, an animal-free and serum-free growth medium that maintains induced pluripotent stem cells in a pluripotent state beyond standard passages. This formulation reduces the reliance on animal-derived lab reagents and lowers the costs associated with stem cell culture and cultivated meat production.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional stem cell culture relies on animal-derived serum, which introduces batch-to-batch variability and ethical concerns. Existing serum-free media may require frequent feeding and lack optimal support for maintaining stem cell pluripotency during extended culture periods.
Solution
The company offers HiDef-B8, a fully defined, animal-free, and serum-free growth medium designed to maintain induced pluripotent stem cells (iPSCs) in a stable, pluripotent state beyond standard passage numbers. This optimized formulation eliminates the inconsistencies associated with animal-derived components, providing a more reliable and ethically sound solution for stem cell culture. HiDef-B8 reduces the need for weekend feeding schedules, streamlining cell culture workflows and minimizing hands-on time. The chemically defined composition ensures consistent performance and reduces experimental variability, leading to more reproducible results in stem cell research and cultivated meat production.
Target Audience
The primary customers are stem cell researchers, cell therapy developers, and cultivated meat producers seeking a reliable, animal-free medium for maintaining and expanding iPSCs.
Features
- Animal-free and serum-free formulation eliminates ethical concerns and batch variability.
- Chemically defined composition ensures consistency and reproducibility.
- Optimized to maintain iPSC pluripotency beyond standard passages.
- Reduces the need for weekend feeding, simplifying cell culture workflows.
- Available in complete and supplement-only formats for flexibility.